793 PATIENTS’ PREFERENCES FOR ACTIVE SURVEILLANCE OR STANDARD ESOPHAGECTOMY AFTER NEOADJUVANT CHEMORADIOTHERAPY: A DISCRETE CHOICE EXPERIMENT IN PATIENTS AFTER STANDARD ESOPHAGECTOMY

Berend Van Der Wilk(Erasmus MC), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Inge Spronk(Association of Dutch Burn Centres), Juanita A. Haagsma(University of Antwerp), Joos Heisterkamp, Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Erwin van der Harst(Radboud University Nijmegen), Ben M. Eyck(Erasmus MC Cancer Institute), Peter‐Paul L. O. Coene(Maasstad Ziekenhuis), Sjoerd M. Lagarde(University of Amsterdam), Bo Jan Noordman(Erasmus MC Cancer Institute)
Diseases of the Esophagus
September 1, 2021
Cited by 0


Related Papers